DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Operating income, 2025
- $1.6B
- YoY, 2025
- +15.6%
- 5-year CAGR
- −4.6%
- 10-year CAGR
- +1.1%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $1.6B | +15.6% |
| 2024 | $1.3B | +6.7% |
| 2023 | $1.3B | −11.6% |
| 2022 | $1.4B | −40.0% |
| 2021 | $2.4B | +20.8% |
| 2020 | $2.0B | +60.1% |
| 2019 | $1.2B | +11.8% |
| 2018 | $1.1B | −5.5% |
| 2017 | $1.2B | −8.8% |
| 2016 | $1.3B | −8.7% |
| 2015 | $1.4B | +42.3% |
| 2014 | $983M | −33.4% |
| 2013 | $1.5B | +22.8% |
| 2012 | $1.2B | +21.7% |
| 2011 | $987M | −23.1% |
| 2010 | $1.3B | −5.6% |
| 2009 | $1.4B | +11.2% |
| 2008 | $1.2B | +12.0% |
| 2007 | $1.1B | — |